Rilutek
Rilutek is a medicine authorised by Swissmedic under authorisation number 53678. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 December 1996 and the authorisation is valid without a time limit. ATC code N07XX02 places the medicine in the group Other nervous system drugs.
| Authorisation number | 53678 |
|---|---|
| Name | Rilutek |
| Full name | Rilutek, comprimés pelliculés |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N07XX02 |
| First authorisation | 17 December 1996 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rilutek, comprimés pelliculés | B | 17 December 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 17 | 56 | Tablette(n) | N07XX02 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rilutek authorised in Switzerland?
Yes. Rilutek is authorised by Swissmedic under authorisation number 53678, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rilutek have?
Rilutek is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rilutek?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.